glp-1 based therapeutics summit 3rd GLP-1-Based 2026 [04/14/26] Upcoming wave of hormone-based therapies

Devine or Eva F

Studies have also explored its impact on oxidative stress and inflammation in various biological models

L., RoyChoudhury, A., & Laferrre, B

Glucagon receptor agonism stimulates hepatic glucose production, increases lipolysis (fat breakdown), promotes fatty acid oxidation in the liver, and elevates resting metabolic rate through thermogenesis

Instead of following the standard titration schedule, where you increase your dose every four weeks until you hit the high maintenance level, microdosers stay at the lowest effective dose for months, or even take less than the starting dose

A pivotal 2021 clinical trial of semaglutide showed that participants lost an average of 15% of their body weight over 68 weeks, compared to just 2% in the placebo group